Collaboration and License Agreement - Narrative (Details) - USD ($) $ in Thousands |
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
Apr. 30, 2022 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | |||
| Revenue | $ 0 | $ 1,885 | |
| Revenue recognized that was included in prior period deferred revenue | 1,300 | ||
| Collaborative Arrangement | |||
| Research and Development Arrangement, Contract to Perform for Others [Line Items] | |||
| Development and regulatory milestones (up to) | 515,000 | ||
| Sales-based milestones (up to) | 740,000 | ||
| Transaction price | $ 32,300 | ||
| Non-refundable upfront cash payment received | 15,000 | ||
| Estimated future reimbursable costs | $ 17,300 | ||
| Revenue | $ 0 | $ 0 | |